Henan Provincial Chest Hospital
10
3
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL)
Role: collaborator
Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD
Role: collaborator
CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery.
Role: collaborator
Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection
Role: collaborator
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes
Role: collaborator
Outcomes of a Novel Magnetically Levitated LVAD: a Multicenter Analysis
Role: collaborator
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
Role: collaborator
Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry
Role: collaborator
EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)
Role: collaborator
HANGZHOU Solution in Bicuspid AS Undergoing TAVR
Role: collaborator
All 10 trials loaded